The MEIS1 gene helps switch other genes on and off during early development, especially in the nervous system, blood cells, and forming organs. This gene plays an important role in guiding how these tissues grow and mature. If it does not work properly, development may be altered, and some people may have a genetic condition affecting growth, learning, or other body systems. More commonly, certain variants near or in the MEIS1 gene are linked to a higher chance of restless legs syndrome rather than a confirmed diagnosis on their own.
What is a gene?
Genes are sections of DNA that give cells instructions for making molecules or managing processes in the body. Some genes provide the code for proteins, which are the cell’s working parts. Others are mainly involved in controlling when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence your response to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
MEIS1Gene function
What if the gene works
The MEIS1 gene helps control when other genes turn on during development. It supports the formation of blood cells and parts of the nervous system, heart, and limbs.
Risk
What if the gene does not work
Changes in the MEIS1 gene are linked most clearly to restless legs syndrome. Milder variants may mainly raise risk, while more severe variants can be tied to developmental differences, including hearing loss and learning or growth problems.
Treatment
What does that mean for your treatment
No MEIS1-specific treatment or drug selection approach is currently established for people with a pathogenic or loss-of-function variant in the MEIS1 gene. The MEIS1 gene is being studied as a biomarker and possible treatment target in some cancers, especially certain leukemias, but this has not changed routine care.
Gene function
What if the gene works
MEIS1 helps cells switch other genes on and off at the right time. This is especially important during early growth, when tissues are taking shape and blood stem cells are being maintained. Understanding how the MEIS1 gene controls development helps show why precise timing matters across the body.
MEIS1 helps turn groups of genes on or off so cells follow the right program. This keeps cell activity organized as tissues grow and mature.
During early development, MEIS1 helps cells respond to location signals so they take on the right role. This supports the orderly shaping of structures such as parts of the limbs and nervous system.
In bone marrow, MEIS1 helps blood stem cells preserve themselves while continuing to produce new blood cells. This supports long-term blood cell formation throughout life.
What is a variant?
A gene variant is a small change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can more substantially alter how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
MEIS1 gene variants can change how strongly this gene control protein turns other genes on or off, especially during development. Some variants slightly reduce MEIS1 activity or alter when and where the protein is made, while more disruptive variants can weaken DNA binding, disrupt partner protein interactions, or stop production of a working protein altogether. This range helps explain how MEIS1 gene variants affect protein function, from mild shifts in gene control to near complete loss of function.
How variants are linked to conditions
Variants in the MEIS1 gene are most clearly linked to restless legs syndrome, especially in people with a family history. Studies also associate some changes in the MEIS1 gene with periodic limb movements during sleep, a related finding that can disrupt sleep quality. The link between the MEIS1 gene and restless legs syndrome reflects a change in risk rather than a diagnosis, so many carriers never develop symptoms.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural variation among people. For many genes, a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a part. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MEIS1, broadly confirmed evidence on specific factors that change gene-related risk is still limited. In people with MEIS1 changes linked to restless legs symptoms, low iron levels, pregnancy, and kidney disease can make symptoms more likely or more noticeable.
Inheritance of MEIS1 variants
There is not yet a broadly confirmed, disease-specific Mendelian pattern for MEIS1 gene inheritance, because most reported MEIS1 findings relate to risk influence rather than a single inherited condition with a well-established dominant or recessive pattern. In practice, how MEIS1 variants are inherited can vary by the specific variant and the health trait being studied. The MEIS1 gene is located on chromosome 2, which is an autosome, so you inherit one copy from each parent.
What does my MEIS1 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific condition for the MEIS1 gene, though this understanding can change as research develops. Some MEIS1 results are linked more to a tendency or higher chance of certain health problems than to a clear-cut inherited condition. If you have a specific MEIS1 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in context.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for MEIS1 variants uses a blood or saliva sample to read this part of your DNA. Results may show a harmless change, a variant linked to risk, or an unclear finding whose health meaning is not yet known. On its own, a result from the MEIS1 gene usually does not confirm a diagnosis.
When should I consider getting a genetic test?
There is not yet a broadly established MEIS1-specific reason for genetic testing in routine care. Testing is usually considered only as part of a broader genetics evaluation, guided by your symptoms, family history, and a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, but how much they explain varies with the condition and the kind of variant involved. Many factors, including age, medical history, environment, and lifestyle, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, it can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or reacts to it at its target. Because of this, the same medication may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It focuses on links between genes and drugs to help explain why the same treatment can work differently from one person to another. With many medicines, genes can influence either how the body handles a drug or how strong its effects are. This information can support better informed, more individualized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the MEIS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing, so any concerns about your health, medicines, or side effects are best discussed with your doctor.
History
The MEIS1 gene first drew attention in the 1990s during studies of mouse leukemia, when researchers identified it near a site where a virus had inserted into DNA. Its name comes from that discovery: myeloid ecotropic viral integration site 1. From these first observations, research expanded steadily. Scientists later recognized that the MEIS1 gene belongs to a family of genes that help guide early body development and blood cell formation. As genetic research advanced, MEIS1 also became known through studies linking common variants to restless legs syndrome, which brought the gene into a wider clinical spotlight. This history made MEIS1 an important example of how one gene can move from cancer research into broader human genetics.